Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 6, Pages -
Publisher
American Society for Microbiology
Online
2020-03-20
DOI
10.1128/aac.00178-20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies
- (2019) Olga Rivero-Menendez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis
- (2019) Miao Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis
- (2019) Sondus Alkhazraji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model
- (2018) Miao Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and in vivo Evaluation of APX001A/APX001 and other Gwt1 inhibitors against Cryptococcus
- (2018) Karen Joy Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Significantly improved pharmacokinetics enhances in vivo efficacy of APX001 against echinocandin and multidrug resistant Candida isolates in a mouse model of invasive candidiasis
- (2018) Yanan Zhao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris
- (2018) Christopher L. Hager et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories
- (2018) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- APX001 is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis
- (2018) Teclegiorgis Gebremariam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- APX001 and Other Gwt1 inhibitor Prodrugs are Effective in Experimental Coccidioides immitis Pneumonia
- (2018) Suganya Viriyakosol et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials
- (2018) David R. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First-in-Human Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects
- (2017) Michael R Hodges et al. Open Forum Infectious Diseases
- Phase 1 Study to Assess Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of APX001 and to Investigate the Effect of Food on APX001 Bioavailability
- (2017) Michael R Hodges et al. Open Forum Infectious Diseases
- Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis
- (2016) Teclegiorgis Gebremariam et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Isavuconazole Therapy Protects Immunosuppressed Mice from Mucormycosis
- (2014) Guanpingsheng Luo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isavuconazole Pharmacodynamic Target Determination for Candida Species in anIn VivoMurine Disseminated Candidiasis Model
- (2013) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Liposomal Amphotericin B and Posaconazole in Intratracheal Models of Murine Mucormycosis
- (2013) Guanpingsheng Luo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CotH3 mediates fungal invasion of host cells during mucormycosis
- (2013) Teclegiorgis Gebremariam et al. JOURNAL OF CLINICAL INVESTIGATION
- Invasive Mold Infections Following Combat-related Injuries
- (2012) T. Warkentien et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of Oral E1210, a New Broad-Spectrum Antifungal with a Novel Mechanism of Action, in Murine Models of Candidiasis, Aspergillosis, and Fusariosis
- (2011) Katsura Hata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
- (2011) Mamiko Miyazaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods
- (2011) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method
- (2011) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now